IGC Pharma Welcomes Industry Leaders to Advisory Board, Supporting Alzheimer's Innovation and AI-Driven Programs
Industry Veterans Bring Deep Strategic Experience to Guide Alzheimer's Clinical Expansion and Commercial Strategy
POTOMAC, MARYLAND / ACCESS Newswire / April 21, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ('IGC Pharma' or the 'Company') today announced the addition of Frank Zaccanelli, Robert K. Coughlin, and Joseph Mangan to its Board of Advisors. The Advisory Board will provide strategic guidance as IGC advances its Alzheimer's drug development and AI driven early dementia detection programs.
Frank Zaccanelli, a seasoned entrepreneur and former President, General Manager, and minority owner of the Dallas Mavericks, under Perot family's majority ownership. He led the development of the American Airlines Center in Dallas Texas and has been a public commentator on finance, politics, global strategy, and brings decades of leadership in venture capital, private equity, and public-private partnerships. Mr. Zaccanelli will support IGC Pharma in identifying and cultivating strategic partnerships, as well as advising on the Company's engagement with brand ambassador and key influencers in the Alzheimer's space.
Robert K. Coughlin, former President and CEO of MassBio, has been a champion of biotech innovation and recently received the 2025 Henri A. Termeer Innovative Leadership Award for his enduring contributions to the life sciences ecosystem. As a cystic fibrosis parent, Bob works tirelessly to raise awareness and invest in companies working on cystic fibrosis. His public service includes time as a Massachusetts State Representative and Undersecretary of Economic Development. Mr. Coughlin will support IGC's Alzheimer's regulatory strategy, clinical engagement, and support relations with pharmaceutical companies.
Joseph H. Mangan is a retired brand strategist, a current Knight of the Order of Malta, and a board member of the New York Athletic Club. Joe has been committed to humanitarian aid and service to those in need. His deep empathy for vulnerable populations, particularly the elderly, aligns closely with IGC Pharma's mission to support Alzheimer's patients and caregivers. Mr. Mangan will advise the Company on strategic partnerships with clinical sites, hospitals, and Alzheimer's foundations.
'We warmly welcome our new members to the Advisory Board and look forward to working together as we advance our Alzheimer's clinical strategy and AI driven early dementia detection programs,' said Ram Mukunda, CEO of IGC Pharma. 'Their diverse expertise across biotechnology, brand strategy, and business development adds meaningful depth to our leadership as we advance our Alzheimer's clinical and AI programs. With their guidance, we are better positioned to scale responsibly, accelerate our mission, and deliver sustained value to both patients and shareholders.'
About IGC Pharma (dba IGC):
IGC Pharma (NYSE American: IGC) is a clinical-stage biotechnology company leveraging AI to develop innovative treatments for Alzheimer's and metabolic disorders. Our lead asset, IGC-AD1, is a cannabinoid-based therapy currently in a Phase 2 trial ( CALMA ) for agitation in Alzheimer's dementia. Our pipeline includes TGR-63, targeting amyloid plaques, and early-stage programs focused on neurodegeneration, tau proteins, and metabolic dysfunctions. We integrate AI to accelerate drug discovery, optimize clinical trials, and enhance patient targeting. With 30 patent filings and a commitment to innovation, IGC Pharma is advancing breakthrough therapies.
Forward-Looking Statements:
This press release contains forward-looking statements. These forward-looking statements are based largely on IGC Pharma's expectations and are subject to several risks and uncertainties, certain of which are beyond IGC Pharma's control. Actual results could differ materially from these forward-looking statements as a result of, among other factors, the Company's failure or inability to commercialize one or more of the Company's products or technologies, including the products or formulations described in this release, or failure to obtain regulatory approval for the products or formulations, where required, or government regulations affecting AI or the AI algorithms not working as intended or producing accurate predictions; general economic conditions that are less favorable than expected; the FDA's general position regarding cannabis- and hemp-based products; and other factors, many of which are discussed in IGC Pharma's U.S. Securities and Exchange Commission ('SEC') filings. IGC incorporates by reference its Annual Report on Form 10-K filed with the SEC on June 24, 2024, and on Form 10-Qs filed with the SEC on August 7, 2024, November 12, 2024, and February 14, 2025, as if fully incorporated and restated herein. Considering these risks and uncertainties, there can be no assurance that the forward-looking information contained in this release will occur.
Contact Information
Rosalyn Christian
IMS Investor Relations
[email protected]
(203) 972-9200
SOURCE: IGC Pharma, Inc.
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
76% of workers have seen senior colleagues resist new tech
This story was originally published on To receive daily news and insights, subscribe to our free daily newsletter. If you're looking for cues as to how your employees will adapt to new technology tools, consider the age profile of the organization's workforce. In a survey of 500 U.S. professionals across various industries conducted by Yooz, a provider of purchase-to-pay automation, more than three-quarters (76%) of all workers witnessed senior colleagues push back against new technology. Furthermore, 55% of millennials (those born 1981 to 1996) said they're 'excited and eager' to try new tools, while only 22% of baby boomers (those born 1946 and 1964) said the same. More than a third (35%) of the baby boomers said they feel cautious or annoyed, or prefer sticking to the old system, when new technology is plugged in. Not a single Gen Z survey participant (those born 1997 and 2012) selected that response. At the same time, about a quarter of Gen Z employees have refused to use a new workplace tool, more than any of the other generations, which Yooz characterized as Gen Z not being 'afraid to say no.' About AI specifically, 35% of Gen Z workers said they 'love' new tools, versus 13% of Boomers. Still, 40% of employees overall said they find AI helpful but unreliable. 'The takeaway: skepticism is still widespread, but younger employees see clear value,' Yooz wrote in its survey report. The report said organizations 'need to manage rollouts carefully: leverage the enthusiasm of younger adopters to build momentum, but also address the concerns of veteran staff who may need more reassurance to get on board.' The key to winning over anyone reluctant to embrace AI is building trust through real-world use cases and support, showcasing quick wins such as an AI tool that saves everyone time on a tedious task, Yooz wrote. Among employees, the most commonly cited need with regard to new technologies is better training on AI tools. More than half (52%) of those polled said their company takes a 'learn-as-you-go' approach, providing only some basic training or documentation. Relatively few employees said their employer provides 'a lot' of training on new tools. This embedded content is not available in your region. And, almost half (48%) of the employees said better training for all would be among the most effective ways to help a company adopt new technology more effectively. The research also delved into the question of who should drive decisions to implement new workplace technology. While younger employees are craving clear direction from the C-suite, at the same time, there is 'a call for more bottom-up input in tech decisions,' according to the survey report. More than a third (35%) of Gen Z respondents said new workplace tools should be chosen by leadership with input from younger employees. Additionally, more than a quarter of Millennial and Gen Z respondents said adoption would improve if leadership embraced change faster and more visibly. A sizable minority (28%) of Gen Z employees said they feel older employees are actively holding back innovation at their company. Yooz advised a collaborative approach to the issue, pairing 'tech-savvy younger employees with veteran staff to share knowledge and encourage cross-generational support during rollouts.' Yooz partnered on the research with Pollfish, a third-party survey platform, and it was conducted in February 2025. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
10 minutes ago
- Bloomberg
Vista CEO expects AI Could Replace 60% of Bankers
Get a jump start on the US trading day with Matt Miller, Katie Greifeld and Sonali Basak on "Bloomberg Open Interest." President Trump and China's Xi Jinping spoke by phone says they cleared up disputes surrounding rare earth exports. Meanwhile, the payrolls report also looms as job cuts pile up around the world... and billionaire Robert Smith sounds the alarm about AI's impact on the workforce. And Dan Mendelson the CEO of Morgan Health joins Bloomberg Open Interest to talk about Trump's order to lower drug prices. (Source: Bloomberg)
Yahoo
13 minutes ago
- Yahoo
OpenAI CEO Sam Altman says AI is ready for entry-level jobs—but unbothered Gen Z have made it their new work friend
Billionaire OpenAI CEO Sam Altman reveals that AI can already perform tasks of junior-level employees—and the ability for it to work days at a time is just around the corner. With fellow tech leaders like Nvidia's Jensen Huang saying those who fail to embrace the technology will be replaced, some Gen Zers are catching on. If you're in desperate need of an intern, there's good news: there may soon be an abundance of them. But they might not be able to fetch you a coffee. OpenAI CEO Sam Altman admitted this week that AI agents—AI-powered systems that can complete job-related tasks with other software tools—can now effectively do the same work as entry-level employees. 'Today (AI) is like an intern that can work for a couple of hours but at some point it'll be like an experienced software engineer that can work for a couple of days,' Altman said on a panel with Snowflake CEO Sridhar Ramaswamy. In the coming months, AI agents will only get exponentially better, Altman said—to the point where their skills are just as good as an experienced software engineer. They're anticipated to operate continuously for days on end, without pause. 'I would bet next year that in some limited cases, at least in some small ways, we start to see agents that can help us discover new knowledge, or can figure out solutions to business problems that are very non-trivial,' the 40-year-old AI CEO added. Fortune reached out to Altman for comment. While this may seem like a grim reality for some workers, the future of human employees' success may depend on following the advice of tech CEOs like Nvidia's Jensen Huang. He predicted those who fail to embrace AI might be the next employee to get the pink slip. 'You're not going to lose your job to an AI, but you're going to lose your job to someone who uses AI,' he said at the Milken Institute's Global Conference last month. Generative AI may be eclipsing the skills of entry-level workers—like conducting research or developing PowerPoints. Some Gen Z have already seen the writing on the wall, and begun embracing the technology more than other age groups. About 51% of Gen Z now view generative AI just like a co-worker or as a friend, according to a recent survey from That's compared to just over 40% of millennials and 35% of Gen X or baby boomers who feel the same way. Altman has gone even further to say that many young people (including millennials) are turning to AI for far more than just internet sleuthing: '(It's a) gross oversimplification, but like older people use ChatGPT as a Google replacement. Maybe people in their 20s and 30s use it as like a life advisor, and then, like people in college use it as an operating system,' Altman said at Sequoia Capital's AI Ascent event earlier this month. 'And there's this other thing where (young people) don't really make life decisions without asking ChatGPT what they should do,' he added. Not all tech leaders have been as upbeat about the future, and have instead used their public appearances to highlight fears of an AI-driven job market reckoning. According to Anthropic CEO Dario Amodei, AI could eliminate half of all entry-level white-collar jobs within five years. Unemployment could skyrocket to 10% to 20%, he told Axios. To put that into context, it's currently at around 4%. Researchers at his company added that the next decade will be 'pretty terrible' for humans as desk jobs are automated, they told tech podcaster Dwarkesh Patel in an interview. This comes as the latest model of Claude—Anthropic's generative AI—can now reportedly code autonomously for nearly seven hours. This story was originally featured on
